BSL_EP044 + lactobacillus BSL_PS6

BSL_EP044 + lactobacillus BSL_PS6 is a **combination probiotic formulation**, likely classified as a medical food or dietary supplement, designed for the nutritional management of metabolic disturbances such as type 2 diabetes. The formulation contains specifically identified probiotic strains intended to support gut microbiome function. The combination acts primarily by restoring the body's production of butyrate and the gut mucin layer. Butyrate stimulates GLP-1 secretion in the gut, which can enhance satiety, reduce appetite, improve insulin secretion, reduce hepatic glucose output, and regulate gastric emptying. This may result in lower postprandial glucose levels and support glycemic control. Clinical evidence suggests a role for probiotic blends in reducing glucose area under the curve and possibly decreasing A1C in adults with type 2 diabetes, particularly as add-on therapy. The formulation is usually taken orally, typically twice daily with food, and is refrigerated after opening. The specific strain BSL_PS6 appears to be a Lactobacillus with properties consistent with immunomodulation, competition with pathogenic organisms, and gut barrier support[1][2][4][6].